Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out
Feb 23 (Reuters) - Novo Nordisk shares fell more than 15% on Monday, wiping away the last gains Wego...
23rd February, 2026
Feb 23 (Reuters) - Novo Nordisk shares fell more than 15% on Monday, wiping away the last gains Wego...
23rd February, 2026
COPENHAGEN, Feb 23 (Reuters) - Novo Nordisk said on Monday its experimental obesity drug CagriSema d...
23rd February, 2026
Feb 23 (Reuters) - Indian IT services company LTIMindtree on Monday said it has won a $100 million d...
23rd February, 2026
Feb 20 (Reuters) - Sonova's full year revenue will come at the lower end of its 2025/2026 forecast r...
20th February, 2026
Feb 17 (Reuters) - The European Commission has approved a higher dose of Novo Nordisk's popular weig...
17th February, 2026

Feb 17 (Reuters) - Medtronic surpassed Wall Street expectations for third-quarter profit on Tuesday,...
17th February, 2026
MILAN, Feb 16 (Reuters) - Exor, the Agnelli family's investment vehicle, and the founder of Lifenet...
16th February, 2026

Feb 14 (Reuters) - Medecins Sans Frontieres has halted "non-critical" medical activities at a major...
14th February, 2026
Feb 11 (Reuters) - Novo Nordisk said on Wednesday it plans to launch its weight-loss pill Wegovy in...
11th February, 2026
FRANKFURT, Feb 11 (Reuters) - One of Germany's leading pharma industry lobby groups has warned that...
11th February, 2026
COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk said on Monday it has filed a lawsuit against U.S. telehe...
9th February, 2026
By Sara Rossi and Cristina Carlevaro CORTINA D'AMPEZZO/TREVISO, Italy, Feb 9 (Reuters) - U.S. skiing...
9th February, 2026